U.S. aid cuts could jeopardize the supply of donated drugs that are hailed for their effectiveness in combating neglected ...

Dr. Reddy's Laboratories and Alvotech have partnered to co-develop, manufacture, and commercialize a biosimilar of Keytruda ...

Alvotech (NASDAQ:ALVO) and Dr. Reddy’s Laboratories (NYSE:RDY) have entered into a collaboration and license agreement to ...

Procter & Gamble said Thursday it plans to cut 7,000 jobs, about 15% of its workforce, over two years. The company said it's ...

Radio Oranje was an integral part of life in the Netherlands during World War II. Not only did it offer hope, but also ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

An analysis of the CALLA study shows that ctDNA is detected an average of 5.5 months before radiographic progression.

Merck wrapped up its recent trading day at $78.27, rising 1.46% and outpacing the sluggish S&P 500. The company’s stock has ...

This was the stock's second consecutive day of gains.

Merck secures U.S. Patent Office backing in its legal battle with Halozyme over Keytruda's injectable version. Read more here ...

Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

Potential import taxes on pharma goods entering the United States continue to have effects on the industry in more ways than ...